SCHEMBL20547217

SCHEMBL20547217

CCOC(=O)N1CCc2noc(-c3ccc(F)cc3)c2CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
HTT P42858 3/20 0.47
MAPT P10636 3/20 0.47
MAPK1 P28482 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP3A4 P08684 1/20 0.46
RAB9A P51151 2/20 0.42
GABRG2 P18507 4/20 0.42
GABRB3 P28472 4/20 0.42
GABRA5 P31644 4/20 0.42
KCNH2 Q12809 4/20 0.42
NPC1 O15118 2/20 0.42
PKM P14618 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
STAT3 P40763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20546709 0.91 LMNA (0.51) LMNAHTTMAPTMAPK1SMN1; SMN2
SCHEMBL20547362 0.89 SMN1; SMN2 (0.53) LMNAHTTMAPTMAPK1SMN1; SMN2
SCHEMBL20547218 0.88 KMT2A (0.51) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL20547288 0.87 LMNA (0.50) LMNAHTTMAPTSMN1; SMN2MEN1
SCHEMBL20547245 0.82 NPC1 (0.53) LMNAMAPTSMN1; SMN2CYP1A2CYP2C19
SCHEMBL20547359 0.82 DPP4 (0.48) LMNAMAPTMAPK1SMN1; SMN2CYP1A2
SCHEMBL20547285 0.81 KCNH2 (0.56) LMNAHTTMAPTMAPK1SMN1; SMN2
SCHEMBL20547293 0.80 NPC1 (0.54) LMNAMAPTSMN1; SMN2KMT2ARAB9A
SCHEMBL20547246 0.78 NPC1 (0.53) LMNAMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL22449924 0.71 CYP1A2 (0.39) CYP1A2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A LMNA 2326/4885HTT 1618/4885MAPT 2729/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A LMNA 2326/4885HTT 1618/4885MAPT 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.